General Manager of Beikang Medical Investment
General Manager of Beijing Enterprises Medical Industry Fund, Vice CEO of Beijing Enterprises Medical and Health Industry Group Limited(02389)
General Manager of Beijing Enterprises Medical Industry Fund, and Vice CEO of Beijing Enterprises Medical and Health Industry Group Limited; Director of Cyttel Bioscience,Xuancheng Cardiovascular Hospital; Director of Hainan Zhonghe Medicine; Master of Guanghua Management School of Peking University; Bachelor of Engineering of Chongqing University; He once worked in the Medical Investment Department of CITICPE, and the CCB International Medical Industry Fund. The main areas of his concerns are medical health, medicine and health.Secretary-General of Medical Health Industry Branch of Peking University Alumni Association; Director of Peking University Guanghua Alumni Foundation; Vice President of ZVAC; medical industry mentor of Dark Horse Club; In recent years, he has delivered speeches at various conferences such as the China Association of Chinese Pharmacists, the China Online Pharmacy Council, the Health Industry Media Forum, and the 21st Century Health China Forum as industry experts. He has repeatedly written articles for domestic and foreign well-known magazines, including "Harvard Business Review", "Tsinghua Financial Review", "Business School".Beijing Enterprises Medical Industry Fund is a market-oriented professional organization under Beijing Enterprises Group and focuses on equity investments in the health care sector of the growth phase and the M & A phase. Fund core contributors includes Hong Kong listed company - Beijing Enterprises Medical, domestic pharmaceutical industry enterprises and local government guidance funds. Its main investment projects are Anhui Xuancheng Cardiovascular Hospital,Cyttel Bioscience(CTCleading enterprises) and Hebei Sen Lang biological (CAR-T cell therapy leading enterprise), etc.